Stay updated on Seladelpar in PBC & Hepatic Impairment Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC & Hepatic Impairment Clinical Trial page.

Latest updates to the Seladelpar in PBC & Hepatic Impairment Clinical Trial page
- ChecktodayChange DetectedA new revision tag Revision: v3.5.5 is added, replacing the previous Revision: v3.5.4 to reflect an updated page version.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s revision was updated from v3.5.3 to v3.5.4, indicating an internal update to the page version. This update does not appear to modify the visible study information or other user-facing content.SummaryDifference0.0%

- Check29 days agoChange DetectedResults were posted on 2026-05-04 and the study title now uses Participants instead of Subjects, reflecting a terminology update. The record also includes added documentation such as the protocol, Statistical Analysis Plan, and IPD sharing information.SummaryDifference12%

- Check44 days agoChange DetectedClinicalTrials.gov’s displayed revision version was updated from **v3.5.2** to **v3.5.3**, reflecting a change in the site build rather than any modification to the study record content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. This appears to be a minor maintenance update.SummaryDifference0.0%

Stay in the know with updates to Seladelpar in PBC & Hepatic Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC & Hepatic Impairment Clinical Trial page.